Chemoinformaics analysis of 2,2,3,3-Tetramethylbutane
| Molecular Weight | 114.232 | nRot | 0 |
| Heavy Atom Molecular Weight | 96.088 | nRig | 6 |
| Exact Molecular Weight | 114.141 | nRing | 0 |
| Solubility: LogS | -2.751 | nHRing | 0 |
| Solubility: LogP | 2.526 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 25.3623 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.556 |
| Synth | 3.599 |
| Natural Product Likeliness | 2.294 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.482 |
| MDCK | 0.0000285 |
| BBB | 0.506 |
| PPB | 0.914936 |
| VDSS | 1.247 |
| FU | 0.133252 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.167 |
| CYP2c19-inh | 0.138 |
| CYP2c19-sub | 0.859 |
| CYP2c9-inh | 0.09 |
| CYP2c9-sub | 0.254 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.544 |
| CYP3a4-inh | 0.021 |
| CYP3a4-sub | 0.377 |
| CL | 6.232 |
| T12 | 0.557 |
| hERG | 0.013 |
| Ames | 0.032 |
| ROA | 0.14 |
| SkinSen | 0.945 |
| Carcinogencity | 0.844 |
| EI | 0.979 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.938385 |